Latest filing published 04 Jun 2025 for The Biotech Growth Trust PLC, €89k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +60.1%Entry £7.62 · Close at T+365 £12.20
- -18.5%Entry £9.60 · Close at T+365 £7.82
- +10.1%Entry £7.70 · Close at T+365 £8.48
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Roger Yates: trading record in brief
All filings by Roger Yates on record concern The Biotech Growth Trust PLC. The record holds 3 filings, for trades running from 14 June 2022 to 4 June 2025.
No open-market sale appears; the market trades are 3 purchases worth €235k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2025 alone, the filings show 1 purchase and no sales.
Half of the purchases are above €89k and half below. Of 3 purchases, 1 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Ninety days after publication, 3 purchases show a median change of +19.7%, with the price up in 100% of them. This is a record of the past, not a forecast.
The latest filing, published on 4 June 2025, reports an open-market purchase of €89k in The Biotech Growth Trust PLC. The median gap between trade and publication is zero days: most filings appear on the same day. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Companies and markets linked to Roger Yates
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ £7.473661.0% of flowLondon Stock Exchange (XLON)ISIN GB0000385517RNS:202506040919PR_NEWS_UKDISCLO_0089Canonical exit: 2 Sept 2025 (T+90)
- 5,000 shares@ £9.6939.0% of flowLondon Stock Exchange (XLON)ISIN GB0000385517RNS:202403140810PR_NEWS_UKDISCLO_0072Canonical exit: 12 Jun 2024 (T+90)
- 10,000 shares@ £7.776438.1% of flowLondon Stock Exchange (XLON)ISIN GB0000385517FCA-NSM:202206140651PR_NEWS_UKDISCLO_0069Canonical exit: 12 Sept 2022 (T+90)
3 of 3 declarations